Women's Hormonal Health Panel

A comprehensive women's hormonal blood panel assessing oestrogen, progesterone, FSH, LH, testosterone, thyroid function, and metabolic markers, interpreted by specialist endocrinologist Dr Cho Li Wei. Designed for menopause assessment, PCOS diagnosis, fertility evaluation, and general female hormonal health.

The Women's Hormonal Health Panel at LW Cho Endocrine Clinic is a specialist-supervised blood testing service tailored to the unique hormonal landscape of women across all life stages — from reproductive years through perimenopause and beyond. The panel is ordered and interpreted by Dr Cho Li Wei, a Fellow of the Royal College of Physicians (London) and Fellow of the Academy of Medicine Singapore, with particular expertise in female reproductive endocrinology. The core hormone panel typically measures oestradiol (E2), progesterone, follicle-stimulating hormone (FSH), luteinising hormone (LH), total and free testosterone, sex hormone-binding globulin (SHBG), anti-Müllerian hormone (AMH), and dehydroepiandrosterone sulphate (DHEA-S). These markers together provide a detailed picture of ovarian reserve, ovulatory function, and androgenic balance. Thyroid function is assessed through TSH, free T3, and free T4, given the high prevalence of thyroid disorders in women and their significant impact on menstrual regularity, mood, weight, and fertility. Prolactin levels are checked where irregular periods or galactorrhoea is a concern. A fasting glucose and HbA1c are typically included to screen for insulin resistance and polycystic ovary syndrome (PCOS), which often co-presents with hormonal imbalances. The panel is clinically indicated across several contexts: perimenopausal women seeking to understand their hormonal trajectory; women with suspected PCOS presenting with irregular periods, acne, or excessive hair growth; patients experiencing unexplained weight gain, fatigue, or mood changes that may have a hormonal basis; and women planning for conception who wish to assess their ovarian reserve. All results are reviewed in a specialist consultation with Dr Cho, who contextualises findings against the patient's age, symptoms, and medical history. Where treatment is indicated — such as hormone replacement therapy, thyroid medication, or metformin for insulin resistance — a personalised management plan is initiated. Follow-up blood panels are scheduled to monitor treatment response and ensure hormonal balance is maintained over time.